title: HIV-related neurocognitive impairment screening: the patient's perspective on its utility and psychological impact.
abstract: Despite ever improving advances in antiretroviral therapy, neurocognitive impairments such as asymptomatic and mild neurocognitive impairment remain a significant problem for the HIV-positive population. We distributed a post-neurocognitive impairment screening service evaluation questionnaire to assess satisfaction and anxiety. Subjects were HIV positive and aged 18-50. They were screened using the Brief Neurocognitive Score and International HIV Dementia Score as well as undergoing screening for anxiety (Generalised Anxiety Disorder Assessment [GAD-7]), depression (Participant Health Questionnaire Mood Scale [PHQ-9]) and memory (Everyday Memory Questionnaire [EMQ-R]). On completion, they were either reassured that the tests were normal or were referred for further investigation. Following assessment, subjects were asked to complete an anonymous satisfaction survey; 101 surveys were analysed. Forty-nine per cent of participants stated that they "felt better" following screening, 43% said it "made no difference", 6% stated it "worried me" and 1% "did not understand". On a scale of 0-10 of helpfulness, the mean score was 7.53. Forty-seven subjects indicated that they were referred for further investigation and 46 subjects that nothing else was needed; 8 reported they did not know. Those referred on rated satisfaction at a mean of 7.54/10 and those with normal screen as 7.09/10 (p = 0.46). Of the groups that were referred for further investigation, 6% said the test "worried them" compared to 4% in the non-referred group. Forty-nine per cent said they "felt better" despite an abnormal result compared to 50% in a normal screening result (p = 0.76). The results of this survey show that screening for neurocognitive impairment by this method is acceptable and helpful to participants. It did not lead to an increase in anxiety and there was no correlation between referred for further investigations and anxiety suggesting concerns about creating undue anxiety by screening and referral are unfounded.
authors.affiliation: a St. Stephen's AIDS Trust , Chelsea and Westminster Hospital , London , UK.
authors.forename: A
authors.initials: A
authors.lastname: Nightingale
authors.forename: D
authors.initials: D
authors.lastname: Ratcliffe
authors.forename: L
authors.initials: L
authors.lastname: Leonidou
authors.forename: A
authors.initials: A
authors.lastname: Margetts
authors.forename: D
authors.initials: D
authors.lastname: Asboe
authors.forename: B
authors.initials: B
authors.lastname: Gazzard
authors.forename: J
authors.initials: J
authors.lastname: Catalan
authors.forename: T J
authors.initials: TJ
authors.lastname: Barber
mesh_terms: D015526:AIDS Dementia Complex / Q000175:diagnosis* / Q000209:etiology; D000293:Adolescent; D000328:Adult; D001008:Anxiety Disorders / Q000523:psychology; D005069:Evaluation Studies as Topic; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000523:psychology; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D009483:Neuropsychological Tests; D011795:Surveys and Questionnaires; D055815:Young Adult
keywords: HIV; anxiety; neurcognitive impairment; screening